Skip to main content
logo
Epitomee Medical Ltd (TLV:EPIT)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
284.40
-3.50 (-1.22%)
Aug 24, 2026, 12:14 PM IDT

Epitomee Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-9.88-8.61-1.46-5.68-15.39-11.52
Depreciation & Amortization
1.231.030.45-0.360.24
Asset Writedown & Restructuring Costs
---6.97---
Stock-Based Compensation
0.430.560.61-1.541.51
Other Operating Activities
0.33-0.92-0.53-2.244.382.7
Change in Accounts Receivable
-0.160.11-0.13-0.17-0.24
Change in Inventory
-0.88-0.45-0.02---
Change in Accounts Payable
0.550.63-0.23--0.831.56
Change in Other Net Operating Assets
0.23---0.36-
Operating Cash Flow
-8.14-7.66-8.29-7.92-9.42-5.76
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.55-1.83-4.62-4.07-3.7-0.4
Investment in Securities
0.035.512.85-9.01-9.5915.58
Other Investing Activities
0.410.61.950.860.17-0.05
Investing Cash Flow
-1.114.2710.18-12.22-13.1215.13

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--0.67-0.52-0.5-0.33-0.22
Net Debt Issued (Repaid)
-0.76-0.67-0.52-0.5-0.33-0.22
Issuance of Common Stock
0.090.060.010.04-52.3
Other Financing Activities
------1.97
Financing Cash Flow
-0.67-0.61-0.51-0.45-0.3350.11

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.241.09-0.440.28-5.49-
Net Cash Flow
-9.68-2.920.94-20.32-28.3659.49

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-9.69-9.49-12.91-12-13.12-6.16
Free Cash Flow Growth
------
Free Cash Flow Margin
-1245.50%-4455.87%--119.96%--
Free Cash Flow Per Share
-0.32-0.32-0.43-0.40-0.45-3.50
Levered Free Cash Flow
-7.57-7.41-4.66-7.4-9.05-4.52
Unlevered Free Cash Flow
-6.8-6.88-4.54-7.37-9.05-2.83

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0.260.28-0.38--0.31.32